DRUGSCAN® & ACM Global Laboratories Viral Testing Services
Efficient and Reliable Viral Testing
Our viral testing services provide critical insight into the health of people and populations by helping inform the much needed protocols for treatment and recovery. Through DRUGSCAN and ACM Global Laboratories' new ViraScan viral testing service, we strive to be the most efficient and reliable lab in the industry—because by making our services available, we’re making healthcare more accessible too.
We’ll partner with you to make collection, testing, and interpreting results easy.
During this pandemic, it’s more important than ever for all people to access lab services that are safe, convenient, and affordable—and we’re working diligently to respond to the public health crisis by making COVID-19 testing accessible.
As the COVID-19 public health emergency continues to worsen with community spread, we are doing our part by providing critical COVID-19 testing. We’re working diligently to support the high demand, and will continue in our commitment to flatten the curve and stop the spread of the virus in communities nationwide.
Results Within 24 Hours
Time is of the essence in diagnosing and stopping the spread of COVID-19. That’s why efficient testing and reliable results are needed now more than ever. Our ViraScan service will deliver results to you within 24 hours of receiving a specimen.
Meeting Community Needs for COVID-19 Testing
Testing is a critical step in care for individuals during this unprecedented time. We support communities by providing easy access to COVID-19 testing for:
Businesses and Corporations
Schools and Universities
Long-Term Care Facilities
Other Large Organizations
COVID-19 Viral Test At-A-Glance
The SARS-CoV-2 PCR molecular test is performed from a nasopharyngeal, saliva and quick nasal swab specimen, using reverse transcription to detect COVID-19’s genetic material—or viral RNA. By detecting the RNA, which will be present in the body before antibodies form or symptoms of the disease are present, the test can tell very early on whether or not someone has the virus. PCR testing may be helpful if you:
With less than 0.2% inconclusive rate and a high specificity rate for testing:
We offer the TaqPath COVID-19 Combo Kit which targets three specific genes (ORF1ab, N Protein, and S Protein) for the qualitative detection of nucleic acid from SARS‑CoV‑2 nasopharyngeal and oropharyngeal swab, nasopharyngeal aspirate, nasal swab, and bronchoalveolar lavage samples.
SalivaNow SARS-CoV-2 Assay Kit
We also now offer the SalivaNow SARS-CoV-2 Assay Kit, a molecular in vitro diagnostic kit intended for the qualitative detection of SARS-CoV-2 in saliva samples. Based on widely used real-time reverse transcription polymerase chain reaction (rRT-PCR) technology, which employs oligonucleotide primers and probes labeled with fluorescent reporter dyes and quenchers, the SalivaNow SARS-CoV-2 Assay detects a conserved region of SARS- CoV-2 nucleocapsid (N) gene as well as sequences to target the human RNase P (RP) for detection of human nucleic acids.
COVID-19 Testing Made Affordable
COVID-19 testing is available with no out-of-pocket cost for individuals. The Families First Coronavirus Response Act & CARES Act requires that group health plans must provide coverage for approved COVID-19 testing without imposing any cost-sharing (including deductibles, copayments and coinsurance), and will also provide claims reimbursement for testing uninsured individuals for COVID-19. ViraScan's SARS-CoV-2 (COVID-19) testing cash price is $100.00.